Debt-to-equity of Elicio Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Elicio Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
Elicio Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 3420%.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Elicio Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	3420%	+5927%		30 Sep 2025
Q2 2025	-735%	-988%	-391%	30 Jun 2025
Q1 2025	-579%	-706%	-558%	31 Mar 2025
Q4 2024	-494%	-414%	-514%	31 Dec 2024
Q3 2024	-2506%	-2479%	-9122%	30 Sep 2024
Q2 2024	253%	+267%		30 Jun 2024
Q1 2024	126%	+136%		31 Mar 2024
Q4 2023	-81%	-67%	-493%	31 Dec 2023
Q3 2023	-27%	-12%	-81%	30 Sep 2023
Q2 2023	-14%	+33%	+70%	30 Jun 2023
Q1 2023	-10%	+850%	+99%	31 Mar 2023
Q4 2022	-14%	-111%	-114%	31 Dec 2022
Q3 2022	-15%	-209%	-108%	30 Sep 2022
Q2 2022	-48%			30 Jun 2022
Q1 2022	-860%			31 Mar 2022
Q4 2021	97%			31 Dec 2021
Q3 2021	194%			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.